An unwanted double: US sales fall for American whiskeys as threats of a trade war heat up
https://www.sandiegouniontribune.com/2025/02/11/whiskey-sales-tariffs/
Feb 11, 2025 - The Distilled Spirits Council says the biggest tariff risk is in the EU.
0
Lipella Pharma Reports Positive Phase 2a Data For LP-310 In Oral Lichen Planus; Stock Up
https://www.rttnews.com/story.aspx?Id=3511347
Feb 11, 2025 - Lipella Pharmaceuticals Inc. (LIPO) Tuesday reported positive topline data from Phase 2a study of LP-310 for the treatment of oral lichen planus (OLP). Following the news, the company's shares were more than 65 percent up in pre-market.
0
Trump steps up his 2018 tariffs on steel and aluminum, risking inflation on promise of more jobs
https://www.boston.com/news/politics/2025/02/10/trump-steps-up-his-2018-tariffs-on-steel-and-aluminum-risking-inflation-on-promise-of-more-jobs/
Feb 10, 2025 -
“We were being pummeled by both friend and foe alike,” Trump said as he signed two proclamations changing his orders during his first term that go into effect on March 4. “It's time for our great industries to come back to America.”
The post Trump steps up his 2018 tariffs on steel and aluminum, risking inflation on promise of more jobs appeared first on Boston.com.
0
Insperity Adj. Earnings Beat Estimates; Stock Up In Pre-market
https://www.rttnews.com/story.aspx?Id=3511032
Feb 10, 2025 - Insperity, Inc. (NSP), a provider of human resources and business performance solutions, Friday reported earnings excluding special items of $0.05 per share, that beat the Street view of $0.02 per share. The company's shares were more than 9 percent up in pre-market.
0
Nektar Therapeutics Gets Fast Track Designation For Rezpegaldesleukin In Atopic Dermatitis; Stock Up
https://www.rttnews.com/story.aspx?Id=3510970
Feb 10, 2025 - Nektar Therapeutics (NKTR) Monday said that the U.S. Food and Drug Administration or FDA has granted Fast Track designation for its drug candidate rezpegaldesleukin for the treatment of atopic dermatitis in patients aged 12 years and older. The company's shares were more than 15 percent up in the pre-market.
0
GSK Stock Up On Q4 Results, Positive Outlook; Plans To Buyback GBP 2 Bln Shares
https://www.rttnews.com/story.aspx?Id=3509593
Feb 05, 2025 - Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, after the British drug maker reported Wednesday a higher fourth-quarter results and issued positive outlook for fiscal 2025. The company further raised its sales view for fiscal 2031, and announced dividends and 2 billion pounds share buyback programme.
0
Estee Lauder to cut up to 7,000 jobs as sales slide
https://www.sandiegouniontribune.com/2025/02/04/estee-lauder-job-cuts/
Feb 04, 2025 - Estee Lauder may trim more than 11% of its workforce.
0
As markets absorb tariff news, it's a wake-up call for individual investors, experts say
https://www.cnbc.com/2025/02/03/as-markets-absorb-tariff-news-its-a-wake-up-call-for-investors-experts.html
Feb 03, 2025 - Plans for new tariffs on Canada and China and Mexico sent stocks falling early Monday. Even as markets recover, experts say it's a wake-up call for investors.
0
As markets buckle up for Trump tariffs, these global sectors brace for a rough ride
https://www.cnbc.com/2025/02/03/global-sectors-most-impacted-trump-tariffs.html
Feb 03, 2025 - U.S. President Donald Trump has jolted global markets with an earlier-than-expected and stringent implementation of tariffs on China, Canada and Mexico.
0
LVMH watch and jewelry CEOs see luxury sales picking up in 2025
https://www.cnbc.com/2025/01/31/lvmh-watches-jewelry-ceos-see-luxury-sales-picking-up.html
Jan 31, 2025 - The CEOs of Tiffany & Co., TAG Heuer and Bulgari and the director of watches for Louis Vuitton weigh in on China sales, tariffs and luxury best-sellers.
0